Sesaminol Ameliorates Metabolic and Alcohol‐Related Liver Injury by Activating the PPARα/Slc27a5 Axis‐Driven Hepatic Fatty Acid β‐Oxidation
Molecular Nutrition & Food Research · 2026
DOI: 10.1002/mnfr.70506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2026. Verfasst von Liujie Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China. Hauptthemen laut MEDLINE: PPAR alpha, Dioxoles, Lignans, Fatty Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Shanghai Polaris Health Co., Ltd, Zhejiang Wuhu Biotechnology Co., Ltd.
Abstract (Originalsprache)
Hepatic diseases pose a major and life‐threatening global health challenge. Sesaminol, a sesame‐seed lignan with antioxidant and anti‐inflammatory properties, was investigated for its ability to combat metabolic dysfunction‐associated fatty liver disease (MAFLD) and alcohol‐related liver injury. Mice fed a high‐fat diet (HFD) or subjected to binge alcohol injury received oral sesaminol to evaluate its protective effects against hepatic dysfunction. Complementary in vitro studies used HepG2 cells to delineate the potential mechanism. Sesaminol reduced body‐weight gain, enhanced glucose tolerance and insulin signaling, lowered hepatic and serum lipid accumulation, and attenuated the inflammatory response in mice. Moreover, sesaminol dose‐dependently reduced triglyceride (TG) accumulation and suppressed pro‐inflammatory cytokines in vitro. Transcriptomic and docking analyses identified peroxisome proliferator‐activated receptor alpha (PPARα) as a direct sesaminol target and revealed solute carrier family 27 member 5 (Slc27a5) as a novel downstream gene. Sesaminol enhanced PPARα occupancy on the Slc27a5 promoter, increased fatty acid uptake, and restored mitochondrial β‐oxidation flux. Therefore, sesaminol may function as a natural PPARα agonist that links fatty acid import to mitochondrial oxidation via Slc27a5, thereby ameliorating hepatic steatosis and inflammation in both metabolic and alcohol‐related liver dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
- College of Pharmacy, Zhejiang University of Technology, Hangzhou, China.
- Institute of Translational Medicine, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Förderung
- Shanghai Polaris Health Co., Ltd
- Zhejiang Wuhu Biotechnology Co., Ltd
Zitieren
APA
Zheng, L., Zhou, J., Jin, H., Long, Y., Zheng, Y., Ding, K., Zheng, Z., Zhuge, F., Fu, Z., & Ni, Y. (2026). Sesaminol Ameliorates Metabolic and Alcohol‐Related Liver Injury by Activating the PPARα/Slc27a5 Axis‐Driven Hepatic Fatty Acid β‐Oxidation. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70506
Vancouver
Zheng L, Zhou J, Jin H, Long Y, Zheng Y, Ding K, et al. Sesaminol Ameliorates Metabolic and Alcohol‐Related Liver Injury by Activating the PPARα/Slc27a5 Axis‐Driven Hepatic Fatty Acid β‐Oxidation. Molecular Nutrition & Food Research. 2026. doi:10.1002/mnfr.70506
BibTeX
@article{Zheng2026,
author = {Zheng, Liujie and Zhou, Jun and Jin, Haojie and Long, Yu and Zheng, Yifan and Ding, Kunying and Zheng, Ziyi and Zhuge, Fen and Fu, Zhengwei and Ni, Yinhua},
title = {Sesaminol Ameliorates Metabolic and Alcohol‐Related Liver Injury by Activating the PPARα/Slc27a5 Axis‐Driven Hepatic Fatty Acid β‐Oxidation},
journal = {Molecular Nutrition & Food Research},
year = {2026},
doi = {10.1002/mnfr.70506}
}
EUVIMED